Connection
Breelyn Wilky to Costimulatory and Inhibitory T-Cell Receptors
This is a "connection" page, showing publications Breelyn Wilky has written about Costimulatory and Inhibitory T-Cell Receptors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.156 |
|
|
|
-
Sebio A, Wilky BA, Keedy VL, Jones RL. The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Future Oncol. 2018 May; 14(12):1197-1211.
Score: 0.156